Geisinger And Celera To Collaborate On Liver Disease Test
Feb 26th 2008Drug InformationLiver Disease / Hepatitis
Geisinger Health System and Celera (NYSE:CRA), an Applera Corporation business, has announced that they have entered into a research collaboration with the aim of developing a diagnostic assay for the increased risk of non-alcoholic steatohepatitis (NASH).
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
